Cancer News | Cancer Updates | Recent updates in cancer treatment, diagnosis | iPharmaCenter
September 29, 2023 The FDA authorized DNA test to detect various cancers The Food and Drug Administration (FDA) authorized first-ever...
top of page
Best selling drugs of 2023 | Top 10 drugs by revenues | Best selling pharmaceuticals | iPharmaCenter
BEST SELLING DRUGS OF 2023 | TOP 10 DRUGS BY REVENUES Also read: Top pharma companies by revenues in 2023 Keytruda (pembrolizumab) -...
Top pharma companies by revenues in 2023|Big Pharma Profits |Top 20 pharma companies | iPharmaCenter
TOP PHARMACEUTICAL COMPANIES BY REVENUES 2023 Merck revenues exclude animal health revenues JOHNSON AND JOHNSON Q1 REVENUES Johnson and...
Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter
BeiGene, a prominent global biotechnology company, has recently shared positive regulatory updates regarding its innovative cancer...
Top selling immunology drugs | Top 10 immunology drugs by revenues | iPharmaCenter
TOP IMMUNOLOGY DRUGS BY REVENUES IN 2022 Humira (Adalimumab): In the realm of immunology drugs, one name stands out as a global success...
Top CMS Pharmaceutical Expenditures: Analyzing High-Expenditure Medications
DRUGS ON WHICH CMS SPENT THE MOST IN 2021 Also read: Top pharma companies by revenues in 2023 Eliquis (Apixaban): Indications: Eliquis is...
Hypertension | News | Updates | iPharmaCenter
Janssen Pharmaceutical has updated the Phase 3 MACiTEPH study, which evaluates macitentan 75mg in patients with Chronic Thromboembolic...
HPV News | Updates | iPharmaCenter
Merck has released a comprehensive publication on the long-term follow-up (LTFU) data for Gardasil 9 (Human Papillomavirus 9-valent...
Chronic rhinosinusitis with nasal polyps | News | Updates | iPharmaCenter
In Japan, the regulatory submission for Nucala (mepolizumab) for chronic rhinosinusitis with nasal polyps was accepted for review by the...
PCSK9 inhibitors | Heart Failure News | Updates | iPharmaCenter
Merck has commenced the Phase 3 clinical program, named CORALreef, for MK-0616. MK-0616 is an investigational oral proprotein convertase...
Deals and Acquisitions | 2023 | Pharma | News | Healthcare | iPharmaCenter
Novo Nordisk and Inversago Pharma have unveiled their collaboration, with Novo Nordisk set to acquire Inversago in a cash transaction of...
Migraine News | Updates | Atogepant | iPharmaCenter
AbbVie has announced the approval of Aquipta (atogepant) by the European Commission for the preventive treatment of migraine in adults...
Chronic spontaneous urticaria | News | Updates |
Novartis has achieved encouraging results in the Phase III trials of remibrutinib, showcasing its effectiveness in managing symptoms of...
10 Most Expensive Drugs | 2023 | Pharmaceuticals | iPharmaCenter
MOST EXPENSIVE PHARMACEUTICALS APPROVED BY THE US FDA 1. Hemgenix (etranacogene dezaparvovec) Cost of therapy: $3.5 million Manufacturer:...
Multiple Sclerosis | News | Blogs | Updates | 2023
Roche reported the Phase II FENopta study of fenebrutinib in adult patients with relapsing forms of multiple sclerosis (RMC). The drug...
Women Health | Menopause News | iPharmaCenter
The US Food and Drug Administration approved Astellas Pharma's Veozah (lasofoxifene) for treating moderate to severe hot flashes...
Meningococcal infection | iPharmaCenter
GlaxoSmithKline (GSK) has presented positive results from the phase III trial of its MenABCWY vaccine candidate at the European Society...
Pharmaceutical Companies Deals and acquisitions | Sanofi | Amgen | Pfizer | 2022 | iPharmaCenter
December 12, 2022 After Sanofi failed to acquire, Amgen announced its plan to acquire Horizon Therapeutics. Amgen announced that it has...
How is AbbVie bracing for the impact of Humira’s biosimilars? | iPharmaCenter
AbbVie’s multibillion blockbuster Humira has been the best-selling product in the industry for several years. It generated $21.2 billion...
TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022
REVENUES OF TOP BIOPHARMACEUTICAL COMPANIES - 2022 1 CHF = 1.01 USD, 1 GBP = 1.16USD; 1EUR= 0.99 USD; 1DKK = 0.13 USD; 1 JPY = 0.0075 USD...
Top-selling cancer drugs | 2022 | 2023 | Best cancer products | iPharmaCenter
CLICK HERE TO CHECK TOP PHARMACEUTICALS BY REVENUES IN 2023 1. Keytruda Revenues: $20.9 billion Indications: Advanced non-small cell lung...
Top 5 drug launches in 2023 that has potential to be blockbusters | iPharmaCenter
FIVE DRUG LAUNCHES IN 2023 THAT HAS POTENTIAL TO BECOME BLOCKBUSTERS Peak revenues are collected from different sources SRP-9001 Patients...
Expected best selling drugs of 2023
ANTICIPATED/EXPECTED BEST SELLING PRODUCTS OF 2023 CLICK HERE TO CHECK TOP PHARMACEUTICALS BY REVENUES IN 2023 Evaluate has published the...
Access to Medicines | 2021 | 2022 | News | iPharmaCenter | GSK tops list
GSK maintains the top place in the Access to Medicines rating in 2022; J&J and AZ followed the list The 2022 Access to Medicine Index was...
Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines
November 07, 2022 Blenrep failed to demonstrate superior PFS versus PomDex in RRMM patients GSK announced that Blenrep (belantamab...
Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter
Merck and Moderna have announced that Merck has exercised its option to collaborate and commercialize the cancer vaccine. The companies...
Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter
Sanofi issued a position statement on the U.S. Zantac litigation. On September 12, 2019, FDA stated that ranitidine-containing medicines,...
AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter
AbbVie announced that its Janus Kinase (JAK) inhibitor was approved by the European Commission for non-radiographic axial...
Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues
Fortune has published the list of top 500 companies, and here is the list of top 20 health care companies. CVS Health CVS Health is an...
Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter
Merck has announced the results of two Phase 3 trials of Keytruda - in combination with Lenvima in unresectable hepatocellular carcinoma...
Expected best selling pharmaceuticals/drugs of 2022
EXPECTED BEST SELLING PRODUCTS OF 2022 Comirnaty (Pfizer) Comirnaty is a messenger RNA (mRNA) based COVID vaccine developed by Pfizer and...
Top pharmaceutical companies by revenues in 2021 | Top 10 pharma companies | iPharmaCenter
TOP BIOPHARMACEUTICAL COMPANIES BY REVENUES IN 2021 Revenues in billions Also read: Italy healthcare system 1. JOHNSON AND JOHNSON Q1...
Collaborations for drug development in Pharma and Healthcare |
Exscientia and Sanofi collaborated to develop AI-driven pipeline medicines, UK based drug discovery companies may receive payments up to...
COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine
December 21, 2022 Sanofi and GSK's VidPrevtyn Beta COVID-19 booster vaccine approved in Great Britain. GSK and Sanofi announced that the...
COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...
Top 20 pharmaceutical companies by revenues in 2020
PHARMACEUTICAL COMPANIES BY REVENUES IN 202O Also check: Top pharmaceutical companies by revenues in 2021 The other big biopharmaceutical...
Myasthenia Gravis News | FDA and EMA approvals |
FDA approved Vyvgart for Myasthenia Gravis FDA announced that it had approved Vyvgart (efgartigimod) for generalized myasthenia gravis...
Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News
December 2021 IQWIG says Rinvoq has added benefit at higher doses, but with safety issues IQWIG has assessed the benefit assessment of...
China released the 2022 NDRL list, Chinese pharma benefited from the list
China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...
European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19
Ronapreve (casirivimab / imdevimab) approved for treating and preventing COVID19 in adults and adolescents Celltrion's Regkirona...
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
ABBVIE RINVOQ AbbVie presented the Phase 3 SELECT-PsA 1 and SELECT-PsA 2 data of Rinvoq in patients with psoriatic arthritis. Rinvoq...
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
The U.N. agency World Health Organisation (WHO) had made a statement on the next WHO chief. WHO announced that the member states proposed...
WHO granted EUL to Covaxin; acclaims easy storage requirement
WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...
FDA approved Novartis Scembli for chronic myeloid leukemia
Novartis announced that the US FDA had approved Scemblix (asciminib) for treating patients with chronic myeloid leukemia. Scemblix...
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
The US FDA approved Biogen's Aduhelm (aducanumab) for Alzheimer's disease. It is the first approved product for AD since 2003 and acts by...
European Commission approved Benlysta for active lupus nephritis
GlaxoSmithKline announced that it received approval for expanded use of Benlysta (belimumab) for lupus nephritis in Europe. The drug is...
France COVID-19 Updates | COVID-19 News in Europe
HAS recommended the user of mRNA vaccines for a population already administered with AstraZeneca vaccine AstraZeneca’s COVID19 vaccine...
American Academy of Dermatology (AAD VMX) Virtual Meeting
AMGEN Otezla Otezla presented a significant improvement in the disease severity in mild-to-moderate patients, according to the Phase 3...
GSK’s Jemperli received approval in Europe and the US for endometrial cancer
GSK has announced that the US FDA has approved Jemperli (dostarlimab), a programmed death receptor-1 (PD-1) for endometrial cancer. The...
Multiple sclerosis News | Tysabri is now available as SC in Europe
Tysabri is now available as SC in Europe Biogen announced that the European Commission had approved the new subcutaneous form of Tysabri...
bottom of page